Establishment Labs Holdings Inc. (NASDAQ: ESTA) Stock Competitors & Peer Comparison
See ESTA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ESTA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ESTA | $67.76 | -3.53% | 2B | -53.78 | -$1.26 | N/A |
| ABT | $103.49 | -0.23% | 179.1B | 19.87 | $5.21 | +2.40% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $89.30 | -1.62% | 114.3B | 16.15 | $5.53 | +3.21% |
| SYK | $273.40 | -0.61% | 104.8B | 20.42 | $13.39 | +1.28% |
| BSX | $44.62 | -0.67% | 66.4B | 14.40 | $3.10 | N/A |
| EW | $86.82 | -2.21% | 50B | 32.15 | $2.70 | N/A |
| DXCM | $87.73 | -2.01% | 33.1B | 34.40 | $2.55 | N/A |
| GEHC | $66.09 | -0.27% | 29.9B | 14.49 | $4.56 | +0.21% |
| PHG | $24.45 | -2.08% | 23.9B | 13.97 | $1.75 | +4.04% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
ESTA vs ABT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ABT has a market cap of 179.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ABT trades at $103.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ABT's P/E ratio is 19.87. In terms of profitability, ESTA's ROE is -2.04%, compared to ABT's ROE of +0.11%. Regarding short-term risk, ESTA is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
ESTA vs BSX-PA Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ESTA's ROE is -2.04%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, ESTA is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
ESTA vs MDT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, MDT has a market cap of 114.3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while MDT trades at $89.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas MDT's P/E ratio is 16.15. In terms of profitability, ESTA's ROE is -2.04%, compared to MDT's ROE of +0.11%. Regarding short-term risk, ESTA is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
ESTA vs SYK Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SYK has a market cap of 104.8B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SYK trades at $273.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SYK's P/E ratio is 20.42. In terms of profitability, ESTA's ROE is -2.04%, compared to SYK's ROE of +0.16%. Regarding short-term risk, ESTA is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
ESTA vs BSX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BSX has a market cap of 66.4B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BSX trades at $44.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BSX's P/E ratio is 14.40. In terms of profitability, ESTA's ROE is -2.04%, compared to BSX's ROE of +0.15%. Regarding short-term risk, ESTA is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
ESTA vs EW Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, EW has a market cap of 50B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while EW trades at $86.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas EW's P/E ratio is 32.15. In terms of profitability, ESTA's ROE is -2.04%, compared to EW's ROE of +0.10%. Regarding short-term risk, ESTA is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
ESTA vs DXCM Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, DXCM has a market cap of 33.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while DXCM trades at $87.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas DXCM's P/E ratio is 34.40. In terms of profitability, ESTA's ROE is -2.04%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, ESTA is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
ESTA vs GEHC Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, GEHC has a market cap of 29.9B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while GEHC trades at $66.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas GEHC's P/E ratio is 14.49. In terms of profitability, ESTA's ROE is -2.04%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, ESTA is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
ESTA vs PHG Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, PHG has a market cap of 23.9B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while PHG trades at $24.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas PHG's P/E ratio is 13.97. In terms of profitability, ESTA's ROE is -2.04%, compared to PHG's ROE of +0.10%. Regarding short-term risk, ESTA is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
ESTA vs ZBH Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ZBH trades at $90.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ZBH's P/E ratio is 10.72. In terms of profitability, ESTA's ROE is -2.04%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, ESTA is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
ESTA vs ABMD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ESTA's ROE is -2.04%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ESTA is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
ESTA vs PEN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while PEN trades at $319.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas PEN's P/E ratio is 83.37. In terms of profitability, ESTA's ROE is -2.04%, compared to PEN's ROE of +0.11%. Regarding short-term risk, ESTA is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
ESTA vs SWAV Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ESTA's ROE is -2.04%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, ESTA is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
ESTA vs SNN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SNN trades at $26.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SNN's P/E ratio is 18.10. In terms of profitability, ESTA's ROE is -2.04%, compared to SNN's ROE of +0.12%. Regarding short-term risk, ESTA is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
ESTA vs ALGN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ALGN has a market cap of 10.6B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ALGN trades at $148.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ALGN's P/E ratio is 13.51. In terms of profitability, ESTA's ROE is -2.04%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, ESTA is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
ESTA vs BIO-B Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BIO-B has a market cap of 10.3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BIO-B trades at $374.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BIO-B's P/E ratio is -65.99. In terms of profitability, ESTA's ROE is -2.04%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, ESTA is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
ESTA vs BIO Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BIO trades at $378.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BIO's P/E ratio is 40.83. In terms of profitability, ESTA's ROE is -2.04%, compared to BIO's ROE of +0.03%. Regarding short-term risk, ESTA is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
ESTA vs GMED Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, GMED has a market cap of 10B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while GMED trades at $73.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas GMED's P/E ratio is 16.66. In terms of profitability, ESTA's ROE is -2.04%, compared to GMED's ROE of +0.12%. Regarding short-term risk, ESTA is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check GMED's competition here
Insulet Corp. (NASDAQ: PODD)
ESTA vs PODD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, PODD has a market cap of 9.5B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while PODD trades at $136.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas PODD's P/E ratio is 23.25. In terms of profitability, ESTA's ROE is -2.04%, compared to PODD's ROE of +0.27%. Regarding short-term risk, ESTA is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
ESTA vs MASI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas MASI's P/E ratio is 44.43. In terms of profitability, ESTA's ROE is -2.04%, compared to MASI's ROE of +0.09%. Regarding short-term risk, ESTA is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
ESTA vs BRKR Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BRKR has a market cap of 9.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BRKR trades at $59.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BRKR's P/E ratio is 29.98. In terms of profitability, ESTA's ROE is -2.04%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, ESTA is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check BRKR's competition here
Glaukos Corporation (NYSE: GKOS)
ESTA vs GKOS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while GKOS trades at $153.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas GKOS's P/E ratio is -178.48. In terms of profitability, ESTA's ROE is -2.04%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, ESTA is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check GKOS's competition here
Bruker Corporation (NASDAQ: BRKRP)
ESTA vs BRKRP Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BRKRP trades at $439.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BRKRP's P/E ratio is 238.95. In terms of profitability, ESTA's ROE is -2.04%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, ESTA is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
ESTA vs HAE Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while HAE trades at $106.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas HAE's P/E ratio is 21.32. In terms of profitability, ESTA's ROE is -2.04%, compared to HAE's ROE of +0.11%. Regarding short-term risk, ESTA is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
ESTA vs NARI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas NARI's P/E ratio is -59.24. In terms of profitability, ESTA's ROE is -2.04%, compared to NARI's ROE of -0.00%. Regarding short-term risk, ESTA is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
ESTA vs ITGR Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ITGR trades at $126.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ITGR's P/E ratio is 19.89. In terms of profitability, ESTA's ROE is -2.04%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, ESTA is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
ESTA vs LIVN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while LIVN trades at $77.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas LIVN's P/E ratio is 18.33. In terms of profitability, ESTA's ROE is -2.04%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, ESTA is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
ESTA vs IRTC Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while IRTC trades at $111.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas IRTC's P/E ratio is -259.88. In terms of profitability, ESTA's ROE is -2.04%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, ESTA is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
ESTA vs AXNX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ESTA's ROE is -2.04%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ESTA is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
ESTA vs TMDX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while TMDX trades at $87.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas TMDX's P/E ratio is 44.16. In terms of profitability, ESTA's ROE is -2.04%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, ESTA is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
ESTA vs NEOG Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while NEOG trades at $13.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas NEOG's P/E ratio is 48.46. In terms of profitability, ESTA's ROE is -2.04%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, ESTA is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
ESTA vs BFLY Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BFLY trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BFLY's P/E ratio is -38.31. In terms of profitability, ESTA's ROE is -2.04%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, ESTA is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
ESTA vs AXGN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while AXGN trades at $43.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas AXGN's P/E ratio is 114.00. In terms of profitability, ESTA's ROE is -2.04%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, ESTA is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
ESTA vs UFPT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while UFPT trades at $287.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas UFPT's P/E ratio is 29.35. In terms of profitability, ESTA's ROE is -2.04%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, ESTA is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
ESTA vs NUVA Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ESTA's ROE is -2.04%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ESTA is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
ESTA vs INSP Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, INSP has a market cap of 2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while INSP trades at $69.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas INSP's P/E ratio is 30.41. In terms of profitability, ESTA's ROE is -2.04%, compared to INSP's ROE of +0.18%. Regarding short-term risk, ESTA is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check INSP's competition here
Novocure Ltd (NASDAQ: NVCR)
ESTA vs NVCR Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while NVCR trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas NVCR's P/E ratio is -12.50. In terms of profitability, ESTA's ROE is -2.04%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, ESTA is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
ESTA vs ATEC Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ATEC trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ATEC's P/E ratio is -167.17. In terms of profitability, ESTA's ROE is -2.04%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, ESTA is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
ESTA vs CNMD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CNMD trades at $45.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CNMD's P/E ratio is 10.07. In terms of profitability, ESTA's ROE is -2.04%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, ESTA is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
ESTA vs HSKA Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ESTA's ROE is -2.04%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ESTA is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
ESTA vs IART Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while IART trades at $15.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas IART's P/E ratio is 6.58. In terms of profitability, ESTA's ROE is -2.04%, compared to IART's ROE of -0.01%. Regarding short-term risk, ESTA is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
ESTA vs AVNS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas AVNS's P/E ratio is 27.77. In terms of profitability, ESTA's ROE is -2.04%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, ESTA is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check AVNS's competition here
Artivion, Inc. (NYSE: AORT)
ESTA vs AORT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while AORT trades at $23.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas AORT's P/E ratio is 39.20. In terms of profitability, ESTA's ROE is -2.04%, compared to AORT's ROE of -0.01%. Regarding short-term risk, ESTA is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check AORT's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
ESTA vs TNDM Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while TNDM trades at $16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas TNDM's P/E ratio is -17.61. In terms of profitability, ESTA's ROE is -2.04%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, ESTA is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
ESTA vs SILK Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SILK's P/E ratio is -18.96. In terms of profitability, ESTA's ROE is -2.04%, compared to SILK's ROE of -0.35%. Regarding short-term risk, ESTA is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
ESTA vs IRMD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while IRMD trades at $86.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas IRMD's P/E ratio is 43.39. In terms of profitability, ESTA's ROE is -2.04%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, ESTA is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
ESTA vs FNA Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas FNA's P/E ratio is -19.83. In terms of profitability, ESTA's ROE is -2.04%, compared to FNA's ROE of -0.35%. Regarding short-term risk, ESTA is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
ESTA vs ENOV Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ENOV trades at $18.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ENOV's P/E ratio is 5.22. In terms of profitability, ESTA's ROE is -2.04%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, ESTA is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
ESTA vs PRCT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while PRCT trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas PRCT's P/E ratio is -9.32. In terms of profitability, ESTA's ROE is -2.04%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, ESTA is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
ESTA vs BBNX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BBNX has a market cap of 998.3M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BBNX trades at $22.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BBNX's P/E ratio is -13.45. In terms of profitability, ESTA's ROE is -2.04%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, ESTA is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check BBNX's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
ESTA vs LMRI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, LMRI has a market cap of 974.3M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while LMRI trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas LMRI's P/E ratio is -19.73. In terms of profitability, ESTA's ROE is -2.04%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, ESTA is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
ESTA vs BVS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BVS has a market cap of 922.1M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BVS trades at $13.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BVS's P/E ratio is 17.91. In terms of profitability, ESTA's ROE is -2.04%, compared to BVS's ROE of +0.28%. Regarding short-term risk, ESTA is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
ESTA vs CBLL Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CBLL has a market cap of 896.2M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CBLL trades at $23.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CBLL's P/E ratio is -13.42. In terms of profitability, ESTA's ROE is -2.04%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, ESTA is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
ESTA vs CSII Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CSII's P/E ratio is -20.83. In terms of profitability, ESTA's ROE is -2.04%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ESTA is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
ESTA vs SIBN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SIBN has a market cap of 824.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SIBN trades at $18.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SIBN's P/E ratio is -54.71. In terms of profitability, ESTA's ROE is -2.04%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, ESTA is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
ESTA vs INMD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, INMD has a market cap of 815.7M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while INMD trades at $14.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas INMD's P/E ratio is 9.85. In terms of profitability, ESTA's ROE is -2.04%, compared to INMD's ROE of +0.12%. Regarding short-term risk, ESTA is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
ESTA vs VREX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas VREX's P/E ratio is 19.42. In terms of profitability, ESTA's ROE is -2.04%, compared to VREX's ROE of +0.05%. Regarding short-term risk, ESTA is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
ESTA vs AHCO Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, AHCO has a market cap of 775.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while AHCO trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas AHCO's P/E ratio is 11.63. In terms of profitability, ESTA's ROE is -2.04%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, ESTA is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
ESTA vs AVR Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, AVR has a market cap of 740.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while AVR trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas AVR's P/E ratio is -3.93. In terms of profitability, ESTA's ROE is -2.04%, compared to AVR's ROE of -0.78%. Regarding short-term risk, ESTA is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
ESTA vs CTKB Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CTKB has a market cap of 733.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CTKB trades at $5.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CTKB's P/E ratio is -30.09. In terms of profitability, ESTA's ROE is -2.04%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, ESTA is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check CTKB's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
ESTA vs SSII Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SSII has a market cap of 622.4M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SSII trades at $3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SSII's P/E ratio is -51.83. In terms of profitability, ESTA's ROE is -2.04%, compared to SSII's ROE of -0.27%. Regarding short-term risk, ESTA is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
ESTA vs SRDX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SRDX's P/E ratio is -34.66. In terms of profitability, ESTA's ROE is -2.04%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, ESTA is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
ESTA vs APEN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas APEN's P/E ratio is -9.43. In terms of profitability, ESTA's ROE is -2.04%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ESTA is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
ESTA vs KIDS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, KIDS has a market cap of 573.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while KIDS trades at $22.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas KIDS's P/E ratio is -18.92. In terms of profitability, ESTA's ROE is -2.04%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, ESTA is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
ESTA vs DCTH Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, DCTH has a market cap of 551M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while DCTH trades at $15.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas DCTH's P/E ratio is 1596.00. In terms of profitability, ESTA's ROE is -2.04%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, ESTA is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
ESTA vs ZIMV Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, ESTA's ROE is -2.04%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, ESTA is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
ESTA vs CERS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CERS has a market cap of 524M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CERS trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CERS's P/E ratio is -86.38. In terms of profitability, ESTA's ROE is -2.04%, compared to CERS's ROE of -0.10%. Regarding short-term risk, ESTA is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
ESTA vs TCMD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, TCMD has a market cap of 505.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while TCMD trades at $22.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas TCMD's P/E ratio is 20.77. In terms of profitability, ESTA's ROE is -2.04%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, ESTA is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
ESTA vs NPCE Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, NPCE has a market cap of 484.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while NPCE trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas NPCE's P/E ratio is -24.93. In terms of profitability, ESTA's ROE is -2.04%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, ESTA is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
ESTA vs SGHT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SGHT has a market cap of 462.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SGHT trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SGHT's P/E ratio is -15.18. In terms of profitability, ESTA's ROE is -2.04%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, ESTA is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SGHT's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
ESTA vs CLPT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CLPT has a market cap of 448.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CLPT trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CLPT's P/E ratio is -12.69. In terms of profitability, ESTA's ROE is -2.04%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, ESTA is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
ESTA vs PACB Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, PACB has a market cap of 437.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while PACB trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas PACB's P/E ratio is -3.44. In terms of profitability, ESTA's ROE is -2.04%, compared to PACB's ROE of -49.62%. Regarding short-term risk, ESTA is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
ESTA vs SENS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SENS has a market cap of 416.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SENS trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SENS's P/E ratio is -4.47. In terms of profitability, ESTA's ROE is -2.04%, compared to SENS's ROE of -1.66%. Regarding short-term risk, ESTA is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
ESTA vs OFIX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, OFIX has a market cap of 371.1M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while OFIX trades at $9.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas OFIX's P/E ratio is -5.98. In terms of profitability, ESTA's ROE is -2.04%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, ESTA is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
ESTA vs SMLR Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas SMLR's P/E ratio is 3.92. In terms of profitability, ESTA's ROE is -2.04%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, ESTA is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check SMLR's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
ESTA vs TLSI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, TLSI has a market cap of 307.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while TLSI trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas TLSI's P/E ratio is -2.98. In terms of profitability, ESTA's ROE is -2.04%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, ESTA is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
ESTA vs CV Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CV has a market cap of 302.3M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CV trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CV's P/E ratio is -9.60. In terms of profitability, ESTA's ROE is -2.04%, compared to CV's ROE of -1.78%. Regarding short-term risk, ESTA is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check CV's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
ESTA vs CATX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, CATX has a market cap of 298.4M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while CATX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas CATX's P/E ratio is -1.97. In terms of profitability, ESTA's ROE is -2.04%, compared to CATX's ROE of -0.42%. Regarding short-term risk, ESTA is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check CATX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
ESTA vs TMCI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas TMCI's P/E ratio is -4.80. In terms of profitability, ESTA's ROE is -2.04%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, ESTA is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
ESTA vs RCEL Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, RCEL has a market cap of 272M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while RCEL trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas RCEL's P/E ratio is -7.60. In terms of profitability, ESTA's ROE is -2.04%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, ESTA is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
ESTA vs INFU Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, INFU has a market cap of 257.5M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while INFU trades at $12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas INFU's P/E ratio is 31.12. In terms of profitability, ESTA's ROE is -2.04%, compared to INFU's ROE of +0.15%. Regarding short-term risk, ESTA is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
ESTA vs MGRM Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas MGRM's P/E ratio is -12.00. In terms of profitability, ESTA's ROE is -2.04%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, ESTA is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
ESTA vs ELMD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ELMD has a market cap of 229.8M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ELMD trades at $27.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ELMD's P/E ratio is 21.18. In terms of profitability, ESTA's ROE is -2.04%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, ESTA is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
ESTA vs NVRO Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ESTA's ROE is -2.04%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ESTA is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
ESTA vs PROF Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, PROF has a market cap of 208.4M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while PROF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas PROF's P/E ratio is -5.85. In terms of profitability, ESTA's ROE is -2.04%, compared to PROF's ROE of -0.56%. Regarding short-term risk, ESTA is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
ESTA vs RXST Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, RXST has a market cap of 200.8M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while RXST trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas RXST's P/E ratio is -4.29. In terms of profitability, ESTA's ROE is -2.04%, compared to RXST's ROE of -0.17%. Regarding short-term risk, ESTA is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check RXST's competition here
Neuronetics, Inc. (NASDAQ: STIM)
ESTA vs STIM Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, STIM has a market cap of 200.4M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while STIM trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas STIM's P/E ratio is -6.55. In terms of profitability, ESTA's ROE is -2.04%, compared to STIM's ROE of -1.51%. Regarding short-term risk, ESTA is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
ESTA vs BSGM Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas BSGM's P/E ratio is -5.81. In terms of profitability, ESTA's ROE is -2.04%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, ESTA is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
ESTA vs MDGS Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas MDGS's P/E ratio is -0.27. In terms of profitability, ESTA's ROE is -2.04%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, ESTA is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
ESTA vs FOCL Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, FOCL has a market cap of 177.7M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while FOCL trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas FOCL's P/E ratio is -4.58. In terms of profitability, ESTA's ROE is -2.04%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, ESTA is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
ESTA vs QIPT Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas QIPT's P/E ratio is -15.87. In terms of profitability, ESTA's ROE is -2.04%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, ESTA is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
ESTA vs LUCD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, LUCD has a market cap of 160M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while LUCD trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas LUCD's P/E ratio is -2.27. In terms of profitability, ESTA's ROE is -2.04%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, ESTA is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check LUCD's competition here
Quantum-Si incorporated (NASDAQ: QSI)
ESTA vs QSI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, QSI has a market cap of 150.1M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas QSI's P/E ratio is -1.65. In terms of profitability, ESTA's ROE is -2.04%, compared to QSI's ROE of -0.47%. Regarding short-term risk, ESTA is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check QSI's competition here
Quanterix Corporation (NASDAQ: QTRX)
ESTA vs QTRX Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, QTRX has a market cap of 148.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while QTRX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas QTRX's P/E ratio is -1.24. In terms of profitability, ESTA's ROE is -2.04%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, ESTA is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
ESTA vs INGN Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, INGN has a market cap of 137.8M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while INGN trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas INGN's P/E ratio is -5.59. In terms of profitability, ESTA's ROE is -2.04%, compared to INGN's ROE of -0.13%. Regarding short-term risk, ESTA is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
ESTA vs ICAD Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ICAD's P/E ratio is -20.37. In terms of profitability, ESTA's ROE is -2.04%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, ESTA is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
ESTA vs ECOR Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ECOR has a market cap of 103M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ECOR trades at $11.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ECOR's P/E ratio is -6.80. In terms of profitability, ESTA's ROE is -2.04%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, ESTA is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
ESTA vs HJLI Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas HJLI's P/E ratio is N/A. In terms of profitability, ESTA's ROE is -2.04%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, ESTA is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for ESTA.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
ESTA vs ASXC Comparison September 2026
Establishment Labs Holdings Inc. (NASDAQ: ESTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESTA stands at 2B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, ESTA is priced at $67.76 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESTA currently has a P/E ratio of -53.78, whereas ASXC's P/E ratio is -1.12. In terms of profitability, ESTA's ROE is -2.04%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, ESTA is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for ESTA.Check ASXC's competition here